Evosep, a leader in proteomics solutions, has relocated to new headquarters in Odense to enhance its role in advancing proteomics for pharmaceutical and biotech industries. The new facility will support innovation and high-precision proteomics techniques. Evosep has also launched Evosep Biolabs for high-throughput proteomics and introduced Installation Qualification and Operational Qualification services to ensure regulatory compliance. The company’s strategic partnership with SCIEX aims to provide end-to-end solutions for drug development, catering to the evolving needs of the pharmaceutical sector. With these developments, Evosep aims to make proteomics a powerful tool for drug discovery and development.
Source link
Evosep expanding capabilities with new headquarters to support rising needs in pharma and biotech for proteomics
